141 related articles for article (PubMed ID: 2680370)
1. Cholecystokinin in the entero-insular axis.
Okabayashi Y; Otsuki M; Baba S
Diabetes Res Clin Pract; 1989; 7 Suppl 1():S79-85. PubMed ID: 2680370
[TBL] [Abstract][Full Text] [Related]
2. Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans.
Verspohl EJ; Ammon HP; Williams JA; Goldfine ID
Diabetes; 1986 Jan; 35(1):38-43. PubMed ID: 3000856
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin is not a major determinant for the changes in beta-cell function seen after pancreatico-biliary diversion in rats.
Gasslander T; Lilja I; Smeds S; Lundquist I; Ihse I
Diabetes Res; 1991 Nov; 18(3):135-42. PubMed ID: 1841824
[TBL] [Abstract][Full Text] [Related]
4. Glucose-dependent insulinotropic action of cholecystokinin and caerulein in the isolated perfused rat pancreas.
Sakamoto C; Otsuki M; Ohki A; Yuu H; Maeda M; Yamasaki T; Baba S
Endocrinology; 1982 Feb; 110(2):398-402. PubMed ID: 6173205
[TBL] [Abstract][Full Text] [Related]
5. Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas.
Okabayashi Y; Otsuki M; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Hasegawa H; Baba S
Pancreas; 1990 May; 5(3):291-7. PubMed ID: 2188254
[TBL] [Abstract][Full Text] [Related]
6. Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas.
Otsuki M; Sakamoto C; Yuu H; Maeda M; Morita S; Ohki A; Kobayashi N; Terashi K; Okano K; Baba S
J Clin Invest; 1979 Mar; 63(3):478-84. PubMed ID: 372241
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of cholecystokinin-induced exocrine secretion by both exogenous and endogenous insulin in isolated and perfused rat pancreata.
Saito A; Williams JA; Kanno T
J Clin Invest; 1980 Apr; 65(4):777-82. PubMed ID: 6987265
[TBL] [Abstract][Full Text] [Related]
8. Effects on exocrine and endocrine rat pancreas of long-term administration of CCK-PZ (cholecystokinin-pancreozymin) or synthetic octapeptide - CCK-PZ.
Arnesjö II; Lundquist I
Scand J Gastroenterol; 1976; 11(5):529-35. PubMed ID: 785590
[TBL] [Abstract][Full Text] [Related]
9. Physiological role of cholecystokinin in meal-induced insulin secretion in conscious rats. Studies with L 364718, a specific inhibitor of CCK-receptor binding.
Rossetti L; Shulman GI; Zawalich WS
Diabetes; 1987 Oct; 36(10):1212-5. PubMed ID: 3308589
[TBL] [Abstract][Full Text] [Related]
10. Effects of CCK on pancreatic function and morphology.
Niederau C; Lüthen R; Heintges T
Ann N Y Acad Sci; 1994 Mar; 713():180-98. PubMed ID: 8185159
[TBL] [Abstract][Full Text] [Related]
11. Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro.
Verspohl EJ; Wunderle G; Ammon HP; Williams JA; Goldfine ID
Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):284-7. PubMed ID: 3012373
[TBL] [Abstract][Full Text] [Related]
12. Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist.
Baum F; Nauck MA; Ebert R; Cantor P; Hoffmann G; Choudhury AR; Schmidt WE; Creutzfeldt W
Digestion; 1992; 53(3-4):189-99. PubMed ID: 1291406
[TBL] [Abstract][Full Text] [Related]
13. Entero-insular axis and diabetes mellitus.
Creutzfeldt W
Horm Metab Res Suppl; 1992; 26():13-8. PubMed ID: 1490680
[TBL] [Abstract][Full Text] [Related]
14. Endogenous opioids modulate the effect of cholecystokinin on insulin release in dogs.
Schusdziarra V; Lenz N; Rewes B; Pfeiffer EF
Neuropeptides; 1984 Nov; 4(6):507-17. PubMed ID: 6096758
[TBL] [Abstract][Full Text] [Related]
15. Integrated actions of cholecystokinin on the gastrointestinal tract: use of the cholecystokinin bioassay.
Liddle RA
Gastroenterol Clin North Am; 1989 Dec; 18(4):735-56. PubMed ID: 2482253
[TBL] [Abstract][Full Text] [Related]
16. Evidence for cholecystokinin receptor subtype in endocrine pancreas.
Verspohl EJ; Hafner B; He X; Knittel JJ
Peptides; 1994; 15(8):1353-60. PubMed ID: 7535422
[TBL] [Abstract][Full Text] [Related]
17. Different inhibitory effects of the newly developed CCK receptor antagonists FK480 and KSG-504 on pancreatic exocrine and endocrine secretion in the isolated perfused rat pancreas.
Kihara Y; Otsuki M
Pancreas; 1995 Mar; 10(2):109-17. PubMed ID: 7716133
[TBL] [Abstract][Full Text] [Related]
18. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas.
Okabayashi Y; Otsuki M; Ohki A; Sakamoto C; Baba S
Endocrinology; 1983 Dec; 113(6):2210-15. PubMed ID: 6196184
[TBL] [Abstract][Full Text] [Related]
19. Glucose-dependent insulinotropic action of cholecystokinin octapeptide in the isolated perfused rat pancreas.
Müller MK; Demol P; Fladrich G; Goebell H; Pederson RA
Digestion; 1983; 27(4):245-51. PubMed ID: 6317502
[TBL] [Abstract][Full Text] [Related]
20. Interactions of cholecystokinin and glucose in rat pancreatic islets.
Zawalich W; Takuwa N; Takuwa Y; Diaz VA; Rasmussen H
Diabetes; 1987 Apr; 36(4):426-33. PubMed ID: 3028890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
